Condition
Liver Fat clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Liver Fat clinical trials that are recruiting, at sites in 3 countries (most in United States (3), United Kingdom (1), Pakistan (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Liver Fat clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Non-invasive blood and imaging tests for metabolic liver disease | — | Miami, Florida and 3 other locations | Recruiting | Aug 14, 2025 |
| Endoscopic sleeve gastroplasty for people with obesity and MASH | — | Boston, Massachusetts and 1 other locations | Recruiting | Nov 18, 2023 |
| Effects of different types of dietary fat on liver and heart health | — | Oxford | Recruiting | Jul 27, 2023 |
| Effects of Ertugliflozin on liver fat and diabetes control in patients with fatty liver disease | Phase 4 | Peshawar, KPK | Recruiting | Dec 9, 2022 |
| Intermittent fasting to treat fatty liver disease in non-obese adults | — | Boston, Massachusetts | Recruiting | May 24, 2021 |
All recruiting trials (5)
-
Non-invasive blood and imaging tests for metabolic liver disease
This project tests whether blood tests and imaging scans can diagnose and stage metabolic-associated steatohepatitis (MASH) and liver fibrosis in adults with metabolic risk factors.
-
Endoscopic sleeve gastroplasty for people with obesity and MASH
This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.
-
Effects of different types of dietary fat on liver and heart health
This study tests how eating different types of fats affects liver and heart health in healthy adults over 28 days.
-
Effects of Ertugliflozin on liver fat and diabetes control in patients with fatty liver disease
This study is testing if the medication Ertugliflozin can help adults with Type 2 Diabetes and fatty liver disease reduce liver fat and improve their blood sugar control.
-
Intermittent fasting to treat fatty liver disease in non-obese adults
This study is testing if intermittent fasting can help non-obese adults with fatty liver disease improve their liver health and overall well-being.
Related topics
Quick answers
How many Liver Fat clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), United Kingdom (1 trial), Pakistan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.